Literature DB >> 9502813

Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse.

Y Zhu1, M S Hsu, J E Pintar.   

Abstract

To characterize further the establishment of the opioid system during prenatal mouse development, we have examined the spatial and temporal expression patterns of mu, kappa, and delta opioid receptor mRNAs and find that the expression patterns of these mRNAs are distinct at all ages. Within the embryo, kappa is the first opioid receptor expressed, with transcripts detected in the gut epithelium as early as embryonic day 9.5 (E9.5). By E10.5, mu receptor expression is first detected in the facial-vestibulocochlear preganglion complex, whereas delta receptor mRNA is first detected at E12.5 in several peripheral tissues, including the olfactory epithelium, heart, limb bud, and tooth. In the brain, both mu and kappa mRNAs are first detected at E11.5 in the basal ganglia and midbrain, respectively. During mid-gestation and late gestation, the expression of both mu and kappa receptors extends to other brain regions that exhibit high expression in the adult, including the medial habenula, hypothalamus, pons, and medulla for mu and the basal ganglia, thalamus, hypothalamus, raphe, and ventral tegmental area for kappa. Thus by E17.5, many aspects of the adult expression patterns of mu and kappa receptors already have been established. Compared with mu and kappa, delta receptor mRNA expression in the brain begins relatively late, and the expression levels remain very low even at E19.5. In contrast to its late appearance in the brain, however, delta is the first opioid receptor expressed in the dorsal root ganglion, at E12.5, before its expression in the spinal cord begins at E15.5. Mu receptor is the first opioid receptor expressed in the spinal cord, at E11.5. These results extend previous ligand-binding data to significantly earlier ages and suggest that early developmental events in both neural and non-neural tissues may be modulated by opioid receptors. Several examples of possible autocrine and paracrine loops of opioid peptide and receptor expression have been identified, suggesting a role for these local circuits in developmental processes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9502813      PMCID: PMC6793117     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  33 in total

1.  Developmental morphology of the subarachnoid space and contiguous structures in the mouse.

Authors:  D G McLone; W Bondareff
Journal:  Am J Anat       Date:  1975-03

Review 2.  Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides.

Authors:  B L Kieffer
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

3.  Endogenous opioids regulate dendritic growth and spine formation in developing rat brain.

Authors:  K F Hauser; P J McLaughlin; I S Zagon
Journal:  Brain Res       Date:  1987-07-21       Impact factor: 3.252

Review 4.  Endogenous opioids, opioid receptors, and neuronal development.

Authors:  I S Zagon
Journal:  NIDA Res Monogr       Date:  1987

5.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

6.  Regional expression and chromosomal localization of the delta opiate receptor gene.

Authors:  T Bzdega; H Chin; H Kim; H H Jung; C A Kozak; W A Klee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

7.  Endogenous opioid peptides: multiple agonists and receptors.

Authors:  J A Lord; A A Waterfield; J Hughes; H W Kosterlitz
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

8.  Opiates selectively increase intracellular calcium in developing type-1 astrocytes: role of calcium in morphine-induced morphologic differentiation.

Authors:  A Stiene-Martin; M P Mattson; K F Hauser
Journal:  Brain Res Dev Brain Res       Date:  1993-12-17

9.  Beta-endorphin is a potent inhibitor of thymidine incorporation into DNA via mu- and kappa-opioid receptors in fetal rat brain cell aggregates in culture.

Authors:  J Barg; M Belcheva; R McHale; R Levy; Z Vogel; C J Coscia
Journal:  J Neurochem       Date:  1993-02       Impact factor: 5.372

10.  Postnatal development of multiple opioid receptors in rat brain.

Authors:  H I Kornblum; D E Hurlbut; F M Leslie
Journal:  Brain Res       Date:  1987-12-15       Impact factor: 3.252

View more
  44 in total

1.  Transcriptional regulation of mouse delta-opioid receptor gene.

Authors:  H C Liu; J T Shen; L B Augustin; J L Ko; H H Loh
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

2.  The Meissner corpuscle revised: a multiafferented mechanoreceptor with nociceptor immunochemical properties.

Authors:  M Paré; R Elde; J E Mazurkiewicz; A M Smith; F L Rice
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

3.  Adaptive evolution of MRG, a neuron-specific gene family implicated in nociception.

Authors:  Sun Shim Choi; Bruce T Lahn
Journal:  Genome Res       Date:  2003-10       Impact factor: 9.043

Review 4.  Selective vulnerability of cerebellar granule neuroblasts and their progeny to drugs with abuse liability.

Authors:  Kurt F Hauser; Valeriya K Khurdayan; Robin J Goody; Avindra Nath; Alois Saria; James R Pauly
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

5.  NGF/PI3K signaling-mediated epigenetic regulation of delta opioid receptor gene expression.

Authors:  Yulong L Chen; Ping-Yee Law; Horace H Loh
Journal:  Biochem Biophys Res Commun       Date:  2008-02-11       Impact factor: 3.575

Review 6.  Peripheral mechanisms of pain and analgesia.

Authors:  Christoph Stein; J David Clark; Uhtaek Oh; Michael R Vasko; George L Wilcox; Aaron C Overland; Todd W Vanderah; Robert H Spencer
Journal:  Brain Res Rev       Date:  2008-12-31

Review 7.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

Review 8.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

9.  Glial-restricted precursors: patterns of expression of opioid receptors and relationship to human immunodeficiency virus-1 Tat and morphine susceptibility in vitro.

Authors:  S K Buch; V K Khurdayan; S E Lutz; P E Knapp; N El-Hage; K F Hauser
Journal:  Neuroscience       Date:  2007-05-02       Impact factor: 3.590

Review 10.  Endogenous morphine/nitric oxide-coupled regulation of cellular physiology and gene expression: implications for cancer biology.

Authors:  George B Stefano; Richard M Kream; Kirk J Mantione; Melinda Sheehan; Patrick Cadet; Wei Zhu; Thomas V Bilfinger; Tobias Esch
Journal:  Semin Cancer Biol       Date:  2007-12-08       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.